Fox Business - The Power to Prosper
Search Site

Wednesday, April 7, 2010 as of 11:14 AM ET

Boston Scientific

The Boston Scientific Corporation () (abbreviated BSC), is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a range of interventional medical specialties, including interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology.

Read More at Wikipedia
SAP Counting on Revamped Cloud Strategy to Boost Company

SAP Co-CEO Jim Hagemann Snabe on the company's strategy change.

Read More

  1. WSJ BLOG/Health: A.M. Vitals: Data For J&J's Zytiga Supports Wider Use

    (This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)Here's what's making health news this morning:J&J Study M...

  2. Boston Scientific To Buy Maker Of Alternative Defibrillators

    Boston Scientific Corp. (BSX) will acquire privately held Cameron Health Inc., which has developed an alternative to traditional defibrillators.Boston Scientific wil...

  3. Boston Scientific CEO Kucheman's 2011 Total Pay Rose 47% To $4.7 Million

    Boston Scientific Corp. (BSX) Chief Executive William H. Kucheman's total pay jumped 47% to $4.7 million last year after he was named interim head of the Natick, Mas...

  4. Boston Scientific To Acquire Cameron Health To Build On Heart-Rhythm Business

    DOW JONES NEWSWIRESBoston Scientific Corp. (BSX) will acquire privately held company Cameron Health Inc., expanding its key heart-rhythm business.Cameron Health deve...

  5. Market For Heart Devices Won't Get A Jolt Anytime Soon

    Don't expect sales of devices that shock the heart to get a jolt anytime soon.The domestic market for implantable cardioverter defibrillators, or ICDs, slumped an es...

  6. Boston Scientific 4Q Net Down 55% As Cardiac Rhythm Sales Fall

    Boston Scientific Corp.'s (BSX) fourth-quarter earnings fell 55% on sales declines in its heart rhythm and drug-eluting stents businesses as the medical-device maker...

  7. Abbott Labs Cuts 700 Jobs Primarily In Manufacturing

    Health-products maker Abbott Laboratories (ABT) has laid off about 700 workers, primarily in manufacturing operations, and plans to eliminate several hundred additio...

  8. Federal Court Finds J&J Stent Patents Invalid

    A federal court ruled that stents marketed by Boston Scientific Corp. (BSX), Abbott Laboratories (ABT), and Medtronic Inc. (MDT) don't infringe on Johnson & Johnson ...

  9. Court Rules Against Johnson & Johnson in Patent Suit

    Boston Scientific Corp said on Monday the U.S. District Court for the District of New Jersey ruled in its favor, finding all patents in a suit brought by Johnson & J...

  10. Boston Scientific Gets Favorable Patent Ruling

    Boston Scientific Corp. said Monday it received a positive ruling in a patent infringement case with Johnson & Johnson involving stents used for heart patients. Bost...

  11. St Jude Therapy Shows Positive Results In Heart Stent Trial

    Patients with coronary artery disease receiving stents placed with a tool marketed by St. Jude Medical Inc. (STJ) had a statistically significant reduction in the ne...

  12. Boston Scientific Lead Gets FDA Nod for Chronic Pain Device

    U.S. officials have approved Boston Scientific ’s (NYSE:BSX) Infinion-branded lead to be used with its new rechargeable chronic pain management device.The company on...

  1. FDA OKs Boston Scientific's New Line of Pacemakers

    U.S. officials gave the green light Monday to Boston Scientific's (NYSE:BSX) new line of pacemakers used to treat bradycardia, a condition in which the heart beats t...

  2. FDA Panel Backs Cameron Health Heart Defibrillator

    A federal advisory panel backed a new type of implantable heart defibrillator being developed by Cameron Health Inc., saying it represents an additional treatment op...

  3. FDA Sees Higher Infection Rate In Study Of New Type Of Heart Defibrillator

    The Food and Drug Administration Monday said patients receiving a new type of heart defibrillator being developed by Cameron Health Inc. had higher rates of infectio...

  4. Boston Scientific Sees Higher Profits, Improving Heart Market

    Boston Scientific Corp.'s (BSX) first-quarter earnings more than doubled as the medical-device maker posted fewer charges and suggested that declines in its heart rh...

  5. eBay, Gilead Among Stocks Up on High Volume Thursday

    These stocks are up on high volume today:Trading with a volume of 38.5 million, or 4.2 times its average daily volume, eBay (NASDAQ:EBAY) is up on high volume today....

  6. Boston Sci Sees Higher Profits, Improving Heart Market

    Boston Scientific Corp.'s (BSX) first-quarter earnings more than doubled as the medical-device maker posted fewer charges, though revenue declined amid a tough marke...

  7. Boston Scientific 1Q Profit More Than Doubles On Fewer Charges

    DOW JONES NEWSWIRESBoston Scientific Corp.'s (BSX) first-quarter earnings surged as the medical-device maker posted fewer charges, though revenue declined amid a tou...

‹ Prev1234Next ›
Freebase CC-BY
Source: Boston Scientific on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL